Loading [MathJax]/jax/output/SVG/jax.js
Review Special Issues

Multiple sclerosis and allergic diseases: is there a relationship?

  • Received: 27 June 2022 Revised: 14 August 2022 Accepted: 17 August 2022 Published: 25 August 2022
  • Immune system disorders characterize various diseases such as multiple sclerosis (MS) and allergic diseases (AD). In MS, T-helper (Th)1 cell phenotype is responsible for the disease onset and long-term evolution. On the other hand, excessive Th2 cell activity has been demonstrated in AD. The simultaneous increase of MS and AD in the same geographical areas, observed in recent years, has questioned the mutually exclusive correlation between MS and AD immunopathogenesis supported by the Th1/Th2 paradigm and has moved the interest in understanding possible overlaps. This manuscript aims to discuss the literature, collected over the past two decades, about the association between MS and AD, and both experimental and epidemiological studies have been reviewed. The results do not provide a solid correlation between AD and MS, although experimental studies support the involvement of the same cells and molecules in the immunopathogenesis of both diseases. Further studies, increasing knowledge on the cellular and molecular mechanisms involved in these two disorders, could help to clarify if a positive or negative association links them and provide the possibility for the development of new therapies.

    Citation: Lisa Aielli, Federica Serra, Erica Costantini. Multiple sclerosis and allergic diseases: is there a relationship?[J]. AIMS Allergy and Immunology, 2022, 6(3): 126-152. doi: 10.3934/Allergy.2022011

    Related Papers:

    [1] Ya-Dong Zhang, Hai-Feng Huo, Hong Xiang . Dynamics of tuberculosis with fast and slow progression and media coverage. Mathematical Biosciences and Engineering, 2019, 16(3): 1150-1170. doi: 10.3934/mbe.2019055
    [2] H. M. Srivastava, Khaled M. Saad, J. F. Gómez-Aguilar, Abdulrhman A. Almadiy . Some new mathematical models of the fractional-order system of human immune against IAV infection. Mathematical Biosciences and Engineering, 2020, 17(5): 4942-4969. doi: 10.3934/mbe.2020268
    [3] Chaoyue Wang, Zhiyao Ma, Shaocheng Tong . Adaptive fuzzy output-feedback event-triggered control for fractional-order nonlinear system. Mathematical Biosciences and Engineering, 2022, 19(12): 12334-12352. doi: 10.3934/mbe.2022575
    [4] Tao-Li Kang, Hai-Feng Huo, Hong Xiang . Dynamics and optimal control of tuberculosis model with the combined effects of vaccination, treatment and contaminated environments. Mathematical Biosciences and Engineering, 2024, 21(4): 5308-5334. doi: 10.3934/mbe.2024234
    [5] Eduardo Ibargüen-Mondragón, M. Victoria Otero-Espinar, Miller Cerón Gómez . A within-host model on the interaction dynamics between innate immune cells and Mycobacterium tuberculosis. Mathematical Biosciences and Engineering, 2025, 22(3): 511-527. doi: 10.3934/mbe.2025019
    [6] Jimin Yu, Jiajun Yin, Shangbo Zhou, Saiao Huang, Xianzhong Xie . An image super-resolution reconstruction model based on fractional-order anisotropic diffusion equation. Mathematical Biosciences and Engineering, 2021, 18(5): 6581-6607. doi: 10.3934/mbe.2021326
    [7] Cristiana J. Silva, Helmut Maurer, Delfim F. M. Torres . Optimal control of a Tuberculosis model with state and control delays. Mathematical Biosciences and Engineering, 2017, 14(1): 321-337. doi: 10.3934/mbe.2017021
    [8] Shuai Zhang, Yongqing Yang, Xin Sui, Yanna Zhang . Synchronization of fractional-order memristive recurrent neural networks via aperiodically intermittent control. Mathematical Biosciences and Engineering, 2022, 19(11): 11717-11734. doi: 10.3934/mbe.2022545
    [9] Georgi Kapitanov . A double age-structured model of the co-infection of tuberculosis and HIV. Mathematical Biosciences and Engineering, 2015, 12(1): 23-40. doi: 10.3934/mbe.2015.12.23
    [10] Wenjie Qin, Jiamin Zhang, Zhengjun Dong . Media impact research: a discrete SIR epidemic model with threshold switching and nonlinear infection forces. Mathematical Biosciences and Engineering, 2023, 20(10): 17783-17802. doi: 10.3934/mbe.2023790
  • Immune system disorders characterize various diseases such as multiple sclerosis (MS) and allergic diseases (AD). In MS, T-helper (Th)1 cell phenotype is responsible for the disease onset and long-term evolution. On the other hand, excessive Th2 cell activity has been demonstrated in AD. The simultaneous increase of MS and AD in the same geographical areas, observed in recent years, has questioned the mutually exclusive correlation between MS and AD immunopathogenesis supported by the Th1/Th2 paradigm and has moved the interest in understanding possible overlaps. This manuscript aims to discuss the literature, collected over the past two decades, about the association between MS and AD, and both experimental and epidemiological studies have been reviewed. The results do not provide a solid correlation between AD and MS, although experimental studies support the involvement of the same cells and molecules in the immunopathogenesis of both diseases. Further studies, increasing knowledge on the cellular and molecular mechanisms involved in these two disorders, could help to clarify if a positive or negative association links them and provide the possibility for the development of new therapies.



    TB is a deadly infectious disease and one of the world's top ten causes of death [1,2,3]. Most of the infected individuals can be cured by adopting a systematical diagnostic and using appropriate antibiotics. However, the impact of TB on human health and social development still cannot be ignored due to the lack of knowledge about TB prevention and diagnosis and the low treatment coverage in some areas. According to the global tuberculosis report 2021 published by the World Health Organization [4], about 9.9 million people worldwide suffered from TB in 2020, of which more than 1.3 million died. The massive destruction caused by TB to the economy and society forces us to understand the transmission mechanism of TB deeply.

    Mathematical models play an essential role in understanding the dynamics of infectious diseases, including TB [5,6,7,8,9,10]. Exploring the transmission mechanism of tuberculosis is the first step to establishing a mathematical model, so references [11,12,13] have studied the transmission dynamics of tuberculosis. In addition, Castillo-Chavez and Feng [14] formulated one-strain and two-strain TB models to analyze the effects of fundamental epidemiological factors. Subsequently, the TB compartment model was proposed by Feng et al. [15] and is considered one of the basic frameworks of the transmission mechanism of TB. The authors in [16] established the TB models with fast and slow dynamics by considering multi-level contact structure. Castillo-Chavez and Song [17] comprehensively summarized the research trends of the tuberculosis dynamic models and control problems in the past decades, and proposed some exciting and challenging questions. It should be pointed out that the research results of [15] indicate that it is not enough to reduce the basic reproduction number to less than 1 for the prevention and control of TB. After that, the researchers further discussed the influence of various factors on the transmission of TB by proposing different dynamical models [18,19,20,21,22,23,24,25]. For example, Hattaf et al. [23] established a TB disease model with exogenous reinfection, and studied the optimal control problem to reduce the infectious group by using Pontryagin's maximum principle. The multi-drug resistance, and case detection and treatment were considered in [24] and [25], respectively. Meanwhile, based on the actual infection data of TB in the United States from 1988 to 2019, the authors in [26] established an SVEITR dynamical model by considering vaccination, incomplete treatment and relapse, and analyzed the sensitivity of basic reproduction number and solved the optimal control problem issue by using Pontryagin's maximum principle.

    It should be pointed out that the models in all of the literature mentioned above are established by using the conventional integer-order calculus, which is a local concept. Fractional-order calculus, as an extension of integer-order one, is a global concept that can more effectively characterize the hereditary and memory properties of many physical processes and materials [27,28]. Therefore, some scholars try to describe the spread and outbreak of infectious disease by using the fractional dynamics model [29,30,31,32,33,34]. The results show that the fractional order model can better fit the actual data. Although the fractional-order model has the above advantages, the control of the fractional TB model is still in the ascendant due to less application of fractional calculus in biology, which is one of the motivations of the current paper.

    Adaptive control is one of the important control methods in engineering [35,36]. Its characteristic is that the control target can be given in advance, and then the control variable can be designed so that the state variable or the related variable of the model can track the control target with small errors, so as to realize the control of the model. Recently, some results adopt the adaptive control method to realize the control of biology [37,38,39]. In particular, the authors in [39] studied the nonlinear adaptive control of COVID-19. However, the system parameters are estimated by the adaptive laws in [37,38,39], which are heavily dependent on the initial values of adaptive laws. Therefore, how to reduce this dependency is also one of the motivations of this paper.

    Motivated by the above discussions, the problem of nonlinear neural networks control is studied for the fractional-order TB model. The main contributions of this paper are summarized as follows: (ⅰ) By analyzing the transmission mechanism of TB and considering the historical dependence on the spreading of TB, a fractional-order TB model under Caputo fractional derivative is established. Compared with the model in [33], in this paper we consider that the proportion of smear-positive and smear-negative from susceptible population is not equal to that from latent population, and the patients after rehabilitation may become susceptible ones again. (ⅱ) This is a successful attempt to apply the universal approximation principle of radial basis function neural networks to biological model, and thus the controllers for fractional-order TB model are proposed and the initial values dependency of adaptive laws are also reduced. Different from [37,38,39], where the model parameters are estimated by adaptive laws, the unknown functions that include model parameters are approximated in this paper, and thus the processes of estimations to model parameters are avoided.

    This paper is organized as follows. The problem to be studied is formulated and some preliminaries are presented in Section 2. The adaptive neural networks controllers are designed and the stability of controlled model is also analyzed in Section 3. Some numerical examples are given in Section 4 to illustrate the proposed controllers. Finally, a brief summary is presented in Section 5.

    Definition 1. [40] The Caputo derivative of function f(t)Cn+1([t0,+),R) with the order α is given as follows

    Dαf(t)=1Γ(nα)tt0f(n)(τ)(tτ)α+1ndτ,

    where Γ() denotes Gamma function, nN+ and n1<αn.

    Definition 2. [40] For α>0, the Mittag-Leffler function with a single parameter is defined as Eα(z)=i=0ziΓ(αi+1), where z is plural. In particular, E1(z)=ez.

    Lemma 1. [40] Let the function f(t)C1([t0,+),R), then Dαf2(t)2f(t)Dαf(t) for tt0 and α(0,1].

    Lemma 2. Consider the system Dαx(t)=φ(t)x(t) with initial value x(0)>0. If 0<α<1 and function φ(t)(t0) is a non-negative and bounded continuous function, then the solution x(t) of this system is positive and bounded.

    Proof. This Lemma can be proven by using the similar method in [44,Lemma 5], so we omit it here.

    Lemma 3. [41] For a given approximation accuracy ˜ϵ>0, any continuous function f(x) defined on a compact set can be approximated by the radial basis function neural networks WTΨ(x) as follows

    f(x)=WTΨ(x)+ϵ(x),|ϵ(x)|˜ϵ,

    where W=argminW[supx|f(x)WTΨ(x)|], x represents the input vector, W=(w1,,wl)TRl denotes the ideal weight vector, l>1 represents the nodes number, Ψ(x)=(Ψ1(x),,Ψl(x))T, Ψi(x) is selected as Ψi(x)=exp[(xσi)T(xσi)/κ2] for i=1,,l, where σi=(σi1,,σin)T and κ are the center and width of the Gaussian function, respectively.

    Since it usually takes four to eight weeks from the time TB enters the body to the time it shows symptoms, and people with TB can have either smear positive or smear negative. Therefore, the people carrying mycobacterium TB is divided into latent population (E), smear positive population (I1) and smear negative population (I2). The rest of the population is classified as susceptible (S) and immune or quarantined due to cure (R). Based on the above division, literature [33] established a dynamic model of TB, discussed the global stability of disease-free equilibrium point and endemic equilibrium point, and analyzed the impact of smear-negative individuals on TB transmission. Considering that the proportion of smear-positive and smear-negative from S is not equal to that from E, and the patients after rehabilitation may become susceptible ones again, we improve the model in [33] to the following one

    {˙S(t)=Π(β1I1+β2I2)SμS+λR,˙E(t)=(1k)(β1I1+β2I2)S(μ+m)E,˙I1(t)=p1k(β1I1+β2I2)S+q1mE(γ1+δ1+μ)I1,˙I2(t)=p2k(β1I1+β2I2)S+q2mE(γ2+δ2+μ)I2,˙R(t)=γ1I1+γ2I2(μ+λ)R, (2.1)

    where Π represents the input rate of the population, β1 and β2 represent the infection rates of smear positive and negative population to susceptible population respectively, μ represents the natural mortality rate, γ1 and γ2 are the cure rates of smear positive and negative population respectively, δ1 and δ2 are the disease-related death rates of smear positive and negative infected persons respectively, λ denotes the transfer rate of the immune or quarantined population that loses immunity or released from quarantine and becomes susceptible again, m represents the transfer rate from latent population to infected population, k represents the proportion of susceptible people who become infected directly after carrying TB bacteria (p1 and p2 represent the proportion of smear positive and negative respectively), q1 and q2 represent the proportion of smear positive and negative respectively in the people who enter the infected population from the latent population. All parameters in model (2.1) are positive except 0p1,p2,q1,q21 and p1+p2=q1+q2=1. The initial values of model (2.1) are S(0)>0,E(0)>0,I1(0)>0,I2(0)>0,R(0)>0.

    In practice, the infection rate of the bacteria and the transfer rate of the population among the compartments depend on the infection rate and transfer rate at each historical moment. That is, it has heritability and memory, which is completely ignored by the integer-order derivative adopted in model (2.1). It is worth noting that the fractional-order derivatives can better describe the genetic and memory characteristics of the process or materials, so the fractional-order compartmental model can be established to better describe the transmission process of mycobacterium TB bacteria in the population based on model (2.1). On the other hand, effective and feasible control measures need to be taken to control the spread of the bacteria in the population. Usually, media coverage for susceptible population to reduce the infection rate and treatment for infected population are the two most commonly used control measures, which are introduced into the fractional-order compartmental model to obtain the following fractional-order control model

    {DαS(t)=Π(β1I1+β2I2)S(1c1u1)μS+λR,DαE(t)=(1k)(β1I1+β2I2)S(1c1u1)(μ+m)E,DαI1(t)=p1k(β1I1+β2I2)S(1c1u1)+q1mE(γ1+δ1+μ)I1c2u2I11+α1I1,DαI2(t)=p2k(β1I1+β2I2)S(1c1u1)+q2mE(γ2+δ2+μ)I2c3u3I21+α2I2,DαR(t)=γ1I1+γ2I2+c2u2I11+α1I1+c3u3I21+α2I2(μ+λ)R, (2.2)

    where α(0,1), c1,c2,c3[0,1] are the effective rate of control measures, u1,u2,u3[0,1] denote the intensity of control measures, α1,α2>0 are half-satiation constants. The reasons why we set u1(t),u2(t),u3(t) as control variables are summarized as follows:

    (ⅰ) Media coverage for susceptible population (u1): after the media coverage to susceptible population, people can take scientific and effective protective measures to reduce the infection rate of the bacteria, which is described by (1c1u1) in (2.2).

    (ⅱ) Treatment to smear positive infected population (u2) and smear negative infected population (u3): due to the limited medical resources, the saturation treatment rate is used to characterize the treatment control measures.

    Remark 1. In references [29,30,31,32], fractional-order TB models were established by considering different factors that influence the transmission of TB, where the fractional derivatives with nonsingular kernel were adopted, while the Caputo fractional derivative is used in model (2.2). Although the Caputo fractional derivative contains a singular kernel, this does not affect the main purpose of this paper: extend the adaptive control and neural networks approximation method widely used in the engineering fields to the biological field, and design control variables for the fractional-order TB model. It should be pointed out that the new and interesting definition of fractional derivative [27,28,42] proposed in recent years can effectively overcome some shortcomings of the traditional fractional derivative, but the stability theory related to these new definition is still relatively lacking, which may lead to difficulties in analyzing the stability of the controlled TB model.

    The control objectives of this paper are as follows: The appropriate expressions of u1,u2,u3 in model (2.2) are designed so that the susceptible population S, smear positive population I1 and smear negative population I2 can track the control targets Sd, I1d and I2d with small errors, respectively. It is assumed that Sd,I1d,I2d and their fractional-order derivative with order α are all bounded and continuously differentiable. In order to achieve the control goal, the following lemma is given.

    Lemma 4. Ω={(S,E,I1,I2,R)|S0,E0,I10,I20,R0,S+E+I1+I2+RΠμ} is a positive invariant set of models (2.1) and (2.2).

    Proof. Lemma 4 can be proved by using similar methods of [43,Theorems 1 and 2], so omitted here.

    In this section, the controllers are designed for the controlled model (2.2) through three steps, and then the stability of the control system is analyzed.

    For convenience, the control errors are defined as follows

    ˜S=SSd,˜I1=I1I1d,˜I2=I2I2d.

    Step 1: The Lyapunov function V1 is constructed as

    V1=12˜S2+12ξ11˜θ21, (3.1)

    where ξ1>0 is a design parameter, ˜θ1=ˆθ1θ1, ˆθ1 is the estimate of θ1=W12, W1 will be defined later. Based on lemma 1, the fractional-order derivative of the function V1 is

    DαV1˜SDα˜S+ξ11˜θ1Dα˜θ1˜S[Π(β1I1+β2I2)S(1c1u1)μS+λRDαSd]+ξ11˜θ1Dα˜θ1=˜S[c1u1S(β1I1+β2I2)DαSd+F1(X1)]+ξ11˜θ1Dα˜θ1,

    where F1(X1)=Π(β1I1+β2I2)SμS+λR, X1=(S,I1,I2,R)T. From Lemma 4, we know that X1 belongs to a compact set, so continuous function F1(X1) can be approximated by radial basis function neural networks. According to Lemma 3, F1(X1) can be approximated as F1(X1)=W1Ψ1(X1)+ϵ1(X1), ϵ1(X1) is the approximation error and satisfies |ϵ1(X1)|<˜ϵ1. Using Young's inequality, we get

    ˜S(W1Ψ1(X1)+ϵ1(X1))|˜S|(W1Ψ1(X1)+˜ϵ1)12a21˜S2θ1ΨT1(X1)Ψ1(X1)+12a21+12˜S2+12˜ϵ21.

    Then, DαV1 can be written as

    DαV1˜S[c1u1S(β1I1+β2I2)+12a21˜Sθ1ΨT1(X1)Ψ1(X1)+12˜SDαSd]+12a21+12˜ϵ21+ξ11˜θ1Dα˜θ1. (3.2)

    The controller u1 and Dαˆθ1 are designed as

    u1=1c1S(β1I1+β2I2)[(ρ1+0.5)˜S12a21˜Sˆθ1ΨT1(X1)Ψ1(X1)+DαSd], (3.3)
    Dαˆθ1=ξ12a21˜S2ΨT1(X1)Ψ1(X1)ˆθ1, (3.4)

    where ρ1>0 is a design parameter. By substituting (3.3) and (3.4) into (3.2) and noting that ˜θ1=ˆθ1θ1, we can obtain

    DαV1ρ1˜S2ξ11˜θ1ˆθ1+12a21+12˜ϵ21.

    Further, since ˜θ1ˆθ1=˜θ21˜θ1θ112˜θ21+12θ21, we get

    DαV1ρ1˜S212ξ11˜θ21+Δ1, (3.5)

    where Δ1=12ξ11θ21+12a21+12˜ϵ21.

    Step 2: The Lyapunov function V2 is constructed as

    V2=12˜I21+12ξ12˜θ22, (3.6)

    where ξ2>0 is a design parameter, ˜θ2=ˆθ2θ2, ˆθ2 is the estimate of θ2=W22, W2 will be defined later. Applying Young's inequality and noticing that u1[0,1], we can obtain

    ˜I1p1k(β1I1+β2I2)S(1u1)12˜I21+p21k2(β1I1+β2I2)2S2+12(1u1)212˜I21+p21k2(β1I1+β2I2)2S2+12. (3.7)

    According to Lemma 1 and using (3.7), we can easily obtain

    DαV2˜I1[c1u2I11+α1I1DαI1d+F2(X2)]+ξ12˜θ2Dα˜θ2+12,

    where F2(X2)=12˜I1p21k2(β1I1+β2I2)2S2+q1mE(γ1+δ1+μ)I1, X2=(S,E,I1,I2,I1d)T. The function F2(X2) can be approximated by radial basis function neural networks because it is continuous and X2 belongs to a compact set. According to Lemma 3, F2(X2) can be approximated as F2(X2)=W2Ψ2(X2)+ϵ2(X2), where |ϵ2(X2)|<˜ϵ2 is the approximation error. Using Young's inequality, we get

    ˜I1F2(X2)|˜I1|(W2Ψ2(X2)+˜ϵ2)12a22˜I21θ2ΨT2(X2)Ψ2(X2)+12a22+12˜I21+12˜ϵ22,

    where a2>0 is a constant. Then, we have

    DαV2˜I1[c1u2I21+α1I1DαI1d+12a22˜I1θ2ΨT2(X2)Ψ2(X2)+12˜I1]+ξ12˜θ2Dα˜θ2+12+12a22+12˜ϵ22.

    Design the controller u2 and adaptive law of ˆθ2 as

    u2=1+α1I1c1I1[(ρ2+12)˜I1+12a22˜I1ˆθ2ΨT2(X2)Ψ2(X2)DαI1d], (3.8)
    Dαˆθ2=ξ22a22˜I21ΨT2(X2)Ψ2(X2)ˆθ2, (3.9)

    where ρ2>0 is a design parameter. Substituting (3.8), (3.9) into DαV2, and using ˜θ2=ˆθ2θ2 and ˜θ2ˆθ212˜θ22+12θ22, we can get

    DαV2ρ2˜I2112ξ12˜θ22+Δ2, (3.10)

    where Δ2=12ξ12θ22+12+12a22+12˜ϵ22.

    Step 3: Similar to step 2, construct the Lyapunov function V3 as

    V3=12˜I22+12ξ13˜θ23, (3.11)

    where ξ3>0 is a designed parameter, ˜θ3=ˆθ3θ3, ˆθ3 is the estimate of θ3=W32, W3 is the weight vector. Similarly, we can design u3 and Dαˆθ3 as

    u3=1+α2I2c2I2[(ρ3+12)˜I2+12a23˜I2ˆθ3ΨT3(X3)Ψ3(X3)DαI2d], (3.12)
    Dαˆθ3=ξ32a23˜I22ΨT3(X3)Ψ3(X3)ˆθ3. (3.13)

    where ρ3>0 is a design parameter, X3=(S,E,I1,I2,I2d)T. Using lemma 1, 3 and Young's inequality, we have

    DαV3ρ3˜I2212ξ13˜θ23+Δ3, (3.14)

    where Δ3=12ξ13θ23+12+12a23+12˜ϵ23.

    Remark 2. In previous works [37,38,39], the vectors to be estimated by adaptive laws were constructed by using the model parameters, with the result that the initial values of adaptive laws have an important influence on the estimated value of the parameter vector. However, in this paper, the functions that contain model parameters are approximated by neural networks, and then the norms of weight vectors are estimated by adaptive laws, so it avoids the estimations to model parameters. Thus, the initial values dependency of adaptive laws are reduced.

    Theorem 1. For control model (2.2), the designed controllers (3.3), (3.8), (3.12) and the adaptive laws (3.4), (3.9), (3.13) can ensure that S, I1 and I2 track the control target Sd, I1d and I2d with small errors, respectively. That is, the control goal can be achieved.

    Proof. According to (3.1), (3.6) and (3.11), constructing Lyapunov function as V(t)=V1+V2+V3. Thus, based on (3.5), (3.10) and (3.14), we have

    DαVρ1˜S2ρ2˜I21ρ3˜I22123i=1ξ1i˜θ2i+ΔρV+Δ,

    where ρ=min{2ρ1,2ρ2,2ρ3,1} and Δ=Δ1+Δ2+Δ3 are positive constants. Since there is 0Eα(ρtα)<1 for any t0, according to [44,Lemma 5], it can be obtained

    V(t)(V(0)Δρ)Eα(ρtα)+ΔρV(0)Eα(ρtα)+Δρ. (3.15)

    From the form of Lyapunov function V1,V2,V3, limtEα(ρtα)=0 and (3.15), the control errors ˜S, ˜I1 and ˜I2 can enter into a small neighborhood of the origin by choosing appropriate parameters Δ and ρ. In other words, under the designed control variables, the control objective of TB model (2.2) can be achieved with small error.

    Remark 3. According to Eqs (3.3), (3.8) and (3.12), the values of u1,u2,u3 will lie outside the interval [0,1] at some time, so, the value of u1,u2,u3 can be adjusted as follows

    ui(t)={1,ui(t)>1,ui(t),0ui(t)1,0,ui(t)<0,i=1,2,3.

    The above adjustment is reasonable, which is mainly because the restriction on the range of control variables will reduce the control effect of the model to a certain extent, but will not affect the stability of the model, which is explained as follows by taking the "Step 1" in Subsection 3.1 as an example. In fact, if u1 is restrict into interval [0,1], then based on Lemma 4 and the assumptions for Sd in Subsection 2.2, we can conclude that the term c1u1S(β1I1+β2I2)+12˜Sθ1ΨT1(Z1)Ψ1(Z1)+12˜SDαSd+ρ1˜S is bounded by a positive constant ζ1. Thus, (3.2) can be rewritten as

    DαV1|˜S|ζ1+˜S[12˜S˜θ1ΨT1(Z1)Ψ1(Z1)+12˜S˜θ1ΨT1(Z1)Ψ1(Z1)ρ1˜S]+12a21+12˜ϵ21+ξ11˜θ1Dα˜θ1.

    According to Lemma 2, we know that ˆθ1 is bounded and thus ˜θ1=ˆθ1θ is bounded, which means that 12˜S˜θ1ΨT1(Z1)Ψ1(Z1) is bounded. Further, by using the boundedness of ˜S, DαV1 can be calculated as

    DαV1ρ1˜S212ξ11˜θ21+ζ2,

    where ζ2>0 is a constant. Therefore, the stability of model (2.2) can be ensured by using the similar argument as in Subsection 3.2. Besides, this restriction also makes it possible to use the control measures in practice, because the control input outside the interval [0,1] is meaningless in practice.

    Remark 4. Although there are many TB models which were built by using different fractional derivative definitions [29,30,31,32], these studies mainly focus on the existence and uniqueness of the solution, dynamic behavior, numerical methods and so on. However, the research results on the control problem of fractional TB model using adaptive control method are relatively scarce. In this paper, we successfully designed the expressions of control variables for the model by using adaptive control method and radial basis function neural networks, and analyzed the stability of the model under control variables.

    This section is devoted to illustrating the theoretical results in previous section by some numerical examples.

    The values of parameters in model (2.2) are chosen as: α=0.95, Π=1.4,β1=5.07394×103,β2=1.01479×103, μ=1/66,m=0.001,k=0.001, p1=0.35,p2=0.65, q1=0.4,q2=0.6, γ1=0.2038,γ2=0.4038, δ1=δ2=0.22, c1=0.7,c2=0.8,c3=0.7, α1=1,α2=1. The designed parameters in the controllers are selected as: ρ1=250,ρ2=ρ3=20, a1=a3=1,a2=2, ξ1=ξ2=ξ3=1. The initial values of model (2.2) and adaptive laws (3.4), (3.9) and (3.13) are (S(0),E(0),I1(0),I2(0),R(0))=(5000,80,40,40,20) and (ˆθ1(0),ˆθ2(0),ˆθ3(0))=(104,105,105), respectively. Finally, the desired values are

    Iid=Ii(0)ebit+rittτ[pik(β1I1(w)+β2I2(w))×S(w)(1c1u1(w))+qimE(w)]dw,(i=1,2)Sd=b3+(S(0)b3)eb4t,

    where τ=3,r1=0.3,r2=0.2, b1=b2=0.4,b3=1500,b4=0.3. The parameters in radial basis function neural networks are chosen as σi=(30,20,10,0,10,20,30)T,κ=10.

    Remark 5. Since the number of infected people at the current time depends on the cumulative number of infected people in the recent period and the initial values, the desired values I1d and I2d are selected as the above forms. Thus, r1 (or r2) represents the proportion of people who enter I1(or I2) from tτ to t and have not recovered at t; I1(0)eb1t(or I2(0)eb2t) refers to the number of patients at the initial time who have not recovered at the current time t. For susceptible populations, our goal is to try to prevent them from contracting the bacteria, that is, to keep as many people as possible in S, which can be achieve by adjusting b3 and b4 in Sd. So, b3 represents the number of people who are still susceptible in the end, and b4 means the rate from S(0) to b3.

    Example 1. Tracking performance of S, I1, I2 to Sd, I1d, I2d, respectively.

    As presented in Section 2, the control objective of this study is to design the controllers such that S, I1, I2 can track desired values Sd, I1d, I2d with small errors, respectively. Thus, we consider the following two cases to verify the effectiveness of the controller and the tracking performance of S,I1,I2 to Sd,I1d,I2d, respectively: Case Ⅰ, τ=2,r1=0.3,r2=0.3, b1=b2=0.4,b3=1500,b4=0.3; Case Ⅱ, τ=2,r1=0.25,r2=0.2, b1=0.5,b2=0.3,b3=2000,b4=0.2. The main reason for choosing the above parameters is that we hope that most people can change their behavior and enter the compartment R through media coverage, and most people can recover after treatment. The simulation results are presented in Figure 1. From Figure 1, we see that the trajectories of S, I1, I2 can track the desired values Sd, I1d, I2d with small errors in both Case Ⅰ and Ⅱ, respectively, which indicate the effectiveness of the proposed controllers. In addition, compared with the case of without control, the number of infected people decreased significantly in both Case Ⅰ and Ⅱ.

    Figure 1.  The tracking performance of S, I1 and I2 under different desired values.

    Example 2. The effect of the fractional-order derivative order α.

    The order α is an important parameter in fractional-order model (2.2), which can be adjusted based on the actual demand. In order to exhibit the effect of α in model (2.2), we choose α=1 (i.e., integer-order model), 0.9,0.8,0.7,0.6, and run the numerical simulations. The results are shown in Figure 2. It can be seen from Figure 2 that with the decrease of α, the convergence speed of the trajectory of S, I1 and I2 are decreasing, that is, the period of TB epidemic is prolonged. This shows that the fractional-order model is more flexible than the integer-order model and has the ability to meet the needs of different situations.

    Figure 2.  The trajectories of S, I1 and I2 under different α.

    Example 3. The effect of different control combinations.

    The purpose of setting control variables in model (2.2) is to prevent as many people as possible from contracting TB. In order to better understand the role of each control measure, we consider the following five cases: Case Ⅰ, u1,u2,u3=0; Case Ⅱ, u1,u3=0,u20; Case Ⅲ, u1,u20,u3=0; Case Ⅳ, u1=0,u2,u30; Case Ⅴ, u1,u2,u30, where ui=0 denotes ui is in absence, and ui0 denotes that control measure ui is adopted (this does not mean that ui has never been equal to zero).

    The simulation results are presented in Figure 3. It follows from Figure 3(a) that, compared with the cases without media coverage (i.e., Cases Ⅰ, Ⅱ, Ⅳ), there are more people who can remain in compartment S when media coverage measures are taken for the susceptible people (i.e., Cases Ⅲ, Ⅳ), which shows that media coverage (u1) is an effective control measure to curb the spread of TB. Figure 3(b) shows the exposed individuals under five cases, which also indicate the significance of media coverage. From Figure 3(c), (d), we know that, when only control measures u2 or u3 (i.e., treatment to the smear positive and negative individuals) are adopted, their effect on reducing the number of TB infections is extremely limited. However, when media coverage and treatment measures are adopted at the same time, the infectious scale of TB epidemic can be greatly reduced. Therefore, we can conclude that comprehensive control measures can be more effective than single ones to prevent the large-scale spread of the bacteria when the TB outbreak occurs. Figure 3(e) presents the trajectories of R. The trajectories of control variables u1,u2 and u3 in Case Ⅴ are given in Figure 3(f).

    Figure 3.  The trajectories of S,E,I1,I2,R and u1,u2,u3 under different control combinations.

    The adaptive neural networks control problem has been investigated for the fractional-order TB model. First, based on the spreading mechanism of TB, a fractional-order compartment model of TB has been established. Then, by using the universal approximation principle of neural networks and constructing Lyapunov functions, adaptive controllers have been designed, which can ensure the control objective can be realized. Finally, some numerical simulations have been presented to illustrate the effectiveness of the proposed controllers. It should be noted that some interesting and meaningful new definitions for fractional-order derivative, including Caputo-Fabrizio, Atangana, Atangana-Baleanu, Losada-Nieto and so on [28,42], have emerged in recent years, which, compared with Caputo derivative adopted in this paper, have nonsingular kernel. Thus, we need to consider the modeling and control problem of TB under these new definition in the future. Meanwhile, some comparisons should be made to explore the advantage and disadvantage of Caputo derivative and other new definitions, which is also one of our future works.

    This work was supported by the Natural Science Foundation of China (12201330).

    The author declares there is no conflicts of interest.



    Conflict of interest



    The authors declare no conflict of interest.

    [1] Akdis M, Akdis CA (2014) Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 133: 621-631. https://doi.org/10.1016/j.jaci.2013.12.1088
    [2] Buckley CD, McGettrick HM (2018) Leukocyte trafficking between stromal compartments: lessons from rheumatoid arthritis. Nat Rev Rheumatol 14: 476-487. https://doi.org/10.1038/s41584-018-0042-4
    [3] Kidd P (2003) Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8: 223-246.
    [4] Romagnani S (2004) Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 113: 395-400. https://doi.org/10.1016/j.jaci.2003.11.025
    [5] Lee GR, Kim ST, Spilianakis CG, et al. (2006) T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24: 369-379. https://doi.org/10.1016/j.immuni.2006.03.007
    [6] Matsuzaki J, Tsuji T, Imazeki I, et al. (2005) Immunosteroid as a regulator for Th1/Th2 balance: its possible role in autoimmune diseases. Autoimmunity 38: 369-375. https://doi.org/10.1080/08916930500124122
    [7] Ngoc PL, Gold DR, Tzianabos AO, et al. (2005) Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 5: 161-166. https://doi.org/10.1097/01.all.0000162309.97480.45
    [8] Podbielska M, Banik NL, Kurowska E, et al. (2013) Myelin recovery in multiple sclerosis: the challenge of remyelination. Brain Sci 3: 1282-1324. https://doi.org/10.3390/brainsci3031282
    [9] Arellano G, Acuña E, Reyes LI, et al. (2017) Th1 and Th17 cells and associated cytokines discriminate among clinically isolated syndrome and multiple sclerosis phenotypes. Front Immunol 8: 753. https://doi.org/10.3389/fimmu.2017.00753
    [10] Wang K, Song F, Fernandez-Escobar A, et al. (2018) The properties of cytokines in multiple sclerosis: pros and cons. Am J Med Sci 356: 552-560. https://doi.org/10.1016/j.amjms.2018.08.018
    [11] Hirahara K, Nakayama T (2016) CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol 28: 163-171. https://doi.org/10.1093/intimm/dxw006
    [12] Wambre E, Bajzik V, DeLong JH, et al. (2017) A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders. Sci Transl Med 9: eaam9171. https://doi.org/10.1126/scitranslmed.aam9171
    [13] Tang C, Inman MD, van Rooijen N, et al. (2001) Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 166: 1471-1481. https://doi.org/10.4049/jimmunol.166.3.1471
    [14] Tang L, Benjaponpitak S, DeKruyff RH, et al. (1998) Reduced prevalence of allergic disease in patients with multiple sclerosis is associated with enhanced IL-12 production. J Allergy Clin Immunol 102: 428-435. https://doi.org/10.1016/S0091-6749(98)70131-9
    [15] Okada H, Kuhn C, Feillet H, et al. (2010) The “hygiene hypothesis” for autoimmune and allergic diseases: an update. Clin Exp Immunol 160: 1-9. https://doi.org/10.1111/j.1365-2249.2010.04139.x
    [16] Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347: 911-920. https://doi.org/10.1056/NEJMra020100
    [17] Cunniffe N, Coles A (2021) Promoting remyelination in multiple sclerosis. J Neurol 268: 30-44. https://doi.org/10.1007/s00415-019-09421-x
    [18] Lazibat I, Rubinić-Majdak M, Županić S (2018) Multiple sclerosis: new aspects of immunopathogenesis. Acta Clin Croat 57: 352-361. https://doi.org/10.20471/acc.2018.57.02.17
    [19] Yamout B, Alroughani R (2018) Multiple sclerosis. Semin Neurol 38: 212-225. https://doi.org/10.1055/s-0038-1649502
    [20] Dobson R, Giovannoni G (2019) Multiple sclerosis—a review. Eur J Neurol 26: 27-40. https://doi.org/10.1111/ene.13819
    [21] Walton C, King R, Rechtman L, et al. (2020) Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 26: 1816-1821. https://doi.org/10.1177/1352458520970841
    [22] Filippi M, Bar-Or A, Piehl F, et al. (2018) Multiple sclerosis. Nat Rev Dis Primers 4: 43. https://doi.org/10.1038/s41572-018-0041-4
    [23] Lassmann H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17: 210-218. https://doi.org/10.1111/j.1750-3639.2007.00064.x
    [24] Kearney H, Altmann DR, Samson RS, et al. (2015) Cervical cord lesion load is associated with disability independently from atrophy in MS. Neurology 84: 367-373. https://doi.org/10.1212/WNL.0000000000001186
    [25] Schiess N, Calabresi PA (2016) Multiple sclerosis. Semin Neurol 36: 350-356. https://doi.org/10.1055/s-0036-1585456
    [26] Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15: 545-558. https://doi.org/10.1038/nri3871
    [27] Amato MP, Ponziani G, Siracusa G, et al. (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol-Chicago 58: 1602-1606. https://doi.org/10.1001/archneur.58.10.1602
    [28] Oh J, Vidal-Jordana A, Montalban X (2018) Multiple sclerosis: clinical aspects. Curr Opin Neurol 31: 752-759. https://doi.org/10.1097/WCO.0000000000000622
    [29] McGinley MP, Goldschmidt CH, Rae-Grant AD (2021) Diagnosis and treatment of multiple sclerosis: a review. JAMA 325: 765-779. https://doi.org/10.1001/jama.2020.26858
    [30] Przybek J, Gniatkowska I, Mirowska-Guzel D, et al. (2015) Evolution of diagnostic criteria for multiple sclerosis. Neurol Neurochir Pol 49: 313-321. https://doi.org/10.1016/j.pjnns.2015.07.006
    [31] Milo R, Miller A (2014) Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev 13: 518-524. https://doi.org/10.1016/j.autrev.2014.01.012
    [32] Garg N, Smith TW (2015) An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav 5: e00362. https://doi.org/10.1002/brb3.362
    [33] Klineova S, Lublin FD (2018) Clinical course of multiple sclerosis. Cold Spring Harb Perspect Med 8: a028928. https://doi.org/10.1101/cshperspect.a028928
    [34] Hart FM, Bainbridge J (2016) Current and emerging treatment of multiple sclerosis. Am J Manag Care 22: s159-s170.
    [35] Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97: 742-768. https://doi.org/10.1016/j.neuron.2018.01.021
    [36] Alfredsson L, Olsson T (2019) Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harb Perspect Med 9: a028944. https://doi.org/10.1101/cshperspect.a028944
    [37] Selter RC, Hemmer B (2013) Update on immunopathogenesis and immunotherapy in multiple sclerosis. ImmunoTargets Ther 2: 21-30. https://doi.org/10.2147/ITT.S31813
    [38] Baxter AG (2007) The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 7: 904-912. https://doi.org/10.1038/nri2190
    [39] Kuerten S, Lichtenegger FS, Faas S, et al. (2006) MBP-PLP fusion protein-induced EAE in C57BL/6 mice. J Neuroimmunol 177: 99-111. https://doi.org/10.1016/j.jneuroim.2006.03.021
    [40] Derdelinckx J, Cras P, Berneman ZN, et al. (2021) Antigen-specific treatment modalities in MS: The past, the present, and the future. Front Immunol 12: 624685. https://doi.org/10.3389/fimmu.2021.624685
    [41] D'Angelo C, Reale M, Costantini E, et al. (2018) Profiling of canonical and non-traditional cytokine levels in interferon-β-treated relapsing-remitting-multiple sclerosis patients. Front Immunol 9: 1240. https://doi.org/10.3389/fimmu.2018.01240
    [42] Marchetti L, Engelhardt B (2020) Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation. Vasc Biol 2: H1-H18. https://doi.org/10.1530/VB-19-0033
    [43] Gold R, Wolinsky JS (2011) Pathophysiology of multiple sclerosis and the place of teriflunomide. Acta Neurol Scand 124: 75-84. https://doi.org/10.1111/j.1600-0404.2010.01444.x
    [44] Holman DW, Klein RS, Ransohoff RM (2011) The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta 1812: 220-230. https://doi.org/10.1016/j.bbadis.2010.07.019
    [45] Sonar SA, Lal G (2018) Blood-brain barrier and its function during inflammation and autoimmunity. J Leukocyte Biol 103: 839-853. https://doi.org/10.1002/JLB.1RU1117-428R
    [46] Thompson AJ, Baranzini SE, Geurts J, et al. (2018) Multiple sclerosis. Lancet 391: 1622-1636. https://doi.org/10.1016/S0140-6736(18)30481-1
    [47] Piehl F (2021) Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis. J Intern Med 289: 771-791. https://doi.org/10.1111/joim.13215
    [48] Claes N, Fraussen J, Stinissen P, et al. (2015) B cells are multifunctional players in multiple sclerosis pathogenesis: Insights from therapeutic interventions. Front Immunol 6: 642. https://doi.org/10.3389/fimmu.2015.00642
    [49] Milo R (2019) Therapies for multiple sclerosis targeting B cells. Croat Med J 60: 87-98. https://doi.org/10.3325/cmj.2019.60.87
    [50] McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8: 913-919. https://doi.org/10.1038/ni1507
    [51] Inglese M (2006) Multiple sclerosis: new insights and trends. Am J Neuroradiol 27: 954-957.
    [52] Voet S, Prinz M, van Loo G (2019) Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends Mol Med 25: 112-123. https://doi.org/10.1016/j.molmed.2018.11.005
    [53] Strik M, Cofré Lizama LE, Shanahan CJ, et al. (2021) Axonal loss in major sensorimotor tracts is associated with impaired motor performance in minimally disabled multiple sclerosis patients. Brain Commun 3: fcab032. https://doi.org/10.1093/braincomms/fcab032
    [54] Akdis CA (2006) Allergy and hypersensitivity: mechanisms of allergic disease. Curr Opin Immunol 18: 718-726. https://doi.org/10.1016/j.coi.2006.09.016
    [55] Murphy K, Travers P, Walport M (2008) Allergy and hypersensitivity. Janeway's Immunobiology. UK: Garland Science. https://doi.org/10.1007/978-3-8274-2219-4
    [56] Simon D (2018) Recent advances in clinical allergy and immunology. Int Arch Allergy Imm 177: 324-333. https://doi.org/10.1159/000494931
    [57] Kumar Y, Bhatia A (2013) Immunopathogenesis of allergic disorders: current concepts. Expert Rev Clin Immunol 9: 211-226. https://doi.org/10.1586/eci.12.104
    [58] Vaillant AAJ, Vashisht R, Zito PM (2022) Immediate hypersensitivity reactions In: StatPearls, Treasure Island (FL): StatPearls Publishing.
    [59] Breiteneder H, Peng YQ, Agache I, et al. (2020) Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy 75: 3039-3068. https://doi.org/10.1111/all.14582
    [60] Galli SJ, Tsai M, Piliponsky AM (2008) The development of allergic inflammation. Nature 454: 445-454. https://doi.org/10.1038/nature07204
    [61] Yao Y, Chen CL, Yu D, et al. (2021) Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy. Allergy 76: 456-470. https://doi.org/10.1111/all.14639
    [62] Muñoz-Carrillo JL, Castro-García FP, Chávez-Rubalcaba F, et al. (2018) Immune system disorders: hypersensitivity and autoimmunity. Immunoregulatory Aspects of Immunotherapy. London: InTechOpen 1-30. https://doi.org/10.5772/intechopen.75794
    [63] Remington B, Broekman HCH, Blom WM, et al. (2018) Approaches to assess IgE mediated allergy risks (sensitization and cross-reactivity) from new or modified dietary proteins. Food Chem Toxicol 112: 97-107. https://doi.org/10.1016/j.fct.2017.12.025
    [64] Kanagaratham C, El Ansari YS, Lewis OL, et al. (2020) IgE and IgG antibodies as regulators of mast cell and basophil functions in food allergy. Front Immunol 11: 603050. https://doi.org/10.3389/fimmu.2020.603050
    [65] Janeway CA, Travers P, Walport M, et al. (2001) Immunobiology: The immune system in health and disease. Effector Mechanisms in Allergic Reactions. New York: Garland Science.
    [66] Kitaura J, Song J, Tsai M, et al. (2003) Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. P Natl Acad Sci USA 100: 12911-12916. https://doi.org/10.1073/pnas.1735525100
    [67] Dispenza MC (2019) Classification of hypersensitivity reactions. Allergy Asthma Proc 40: 470-473. https://doi.org/10.2500/aap.2019.40.4274
    [68] Miyake K, Karasuyama H (2017) Emerging roles of basophils in allergic inflammation. Allergol Int 66: 382-391. https://doi.org/10.1016/j.alit.2017.04.007
    [69] Prussin C, Metcalfe DD (2006) 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 117: S450-S456. https://doi.org/10.1016/j.jaci.2005.11.016
    [70] Sampson AP (2000) The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy 30: 22-27. https://doi.org/10.1046/j.1365-2222.2000.00092.x
    [71] Drazdauskaitė G, Layhadi JA, Shamji MH (2020) Mechanisms of allergen immunotherapy in allergic rhinitis. Curr Allergy Asthma Rep 21: 2. https://doi.org/10.1007/s11882-020-00977-7
    [72] Akhouri S, House SA (2022) >Allergic rhinitis In: StatPearls, Treasure Island (FL): StatPearls Publishing.
    [73] Yu W, Freeland DMH, Nadeau KC (2016) Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol 16: 751-765. https://doi.org/10.1038/nri.2016.111
    [74] Iweala OI, Choudhary SK, Commins SP (2018) Food allergy. Curr Gastroenterol Rep 20: 17. https://doi.org/10.1007/s11894-018-0624-y
    [75] Peters RL, Krawiec M, Koplin JJ, et al. (2021) Update on food allergy. Pediatr Allergy Immu 32: 647-657. https://doi.org/10.1111/pai.13443
    [76] Rehman A, Amin F, Sadeeqa S (2018) Prevalence of asthma and its management: A review. J Pak Med Assoc 68: 1823-1827.
    [77] Ogeyingbo OD, Ahmed R, Gyawali M, et al. (2021) The relationship between vitamin D and asthma exacerbation. Cureus 13: e17279. https://doi.org/10.1111/pai.13443
    [78] Bush A (2019) Pathophysiological mechanisms of asthma. Front Pediatr 7: 68. https://doi.org/10.3389/fped.2019.00068
    [79] Nakamura Y, Tamaoki J, Nagase H, et al. (2020) Japanese guidelines for adult asthma. Allergol Int 69: 519-548. https://doi.org/10.1016/j.alit.2020.08.001
    [80] Bilò MB, Martini M, Tontini C, et al. (2021) Anaphylaxis. Eur Ann Allergy Clin Immunol 53: 4-17. https://doi.org/10.23822/EurAnnACI.1764-1489.158
    [81] Pflipsen MC, Colon KMV (2020) Anaphylaxis: recognition and management. Am Fam Physician 102: 355-362.
    [82] Hackett TL, Singhera GK, Shaheen F, et al. (2011) Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to respiratory syncytial virus and air pollution. Am J Resp Cell Mol 45: 1090-1100. https://doi.org/10.1165/rcmb.2011-0031OC
    [83] Siddiqui S, Johansson K, Joo A, et al. (2021) Epithelial miR-141 regulates IL-13-induced airway mucus production. JCI Insight 6: e139019. https://doi.org/10.1172/jci.insight.139019
    [84] Vercelli D (2008) Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 8: 169-182. https://doi.org/10.1038/nri2257
    [85] Akdis CA (2021) Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?. Nat Rev Immunol 21: 739-751. https://doi.org/10.1038/s41577-021-00538-7
    [86] Kansen HM, Lebbink MA, Mul J, et al. (2020) Risk factors for atopic diseases and recurrent respiratory tract infections in children. Pediatr Pulm 55: 3168-3179. https://doi.org/10.1002/ppul.25042
    [87] D'Amato G, Chong-Neto HJ, Ortega OPM, et al. (2020) The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens. Allergy 75: 2219-2228. https://doi.org/10.1111/all.14476
    [88] Prescott S, Saffery R (2011) The role of epigenetic dysregulation in the epidemic of allergic disease. Clin Epigenetics 2: 223-232. https://doi.org/10.1007/s13148-011-0028-4
    [89] Wilson CB, Rowell E, Sekimata M (2009) Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 9: 91-105. https://doi.org/10.1038/nri2487
    [90] Thorburn AN, Macia L, Mackay CR (2014) Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 40: 833-842. https://doi.org/10.1016/j.immuni.2014.05.014
    [91] Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296: 490-494. https://doi.org/10.1126/science.296.5567.490
    [92] Frei R, Lauener RP, Crameri R, et al. (2012) Microbiota and dietary interactions: an update to the hygiene hypothesis?. Allergy 67: 451-461. https://doi.org/10.1111/j.1398-9995.2011.02783.x
    [93] Raj D, Kabra SK, Lodha R (2014) Childhood obesity and risk of allergy or asthma. Immunol Allergy Clin 34: 753-765. https://doi.org/10.1016/j.iac.2014.07.001
    [94] Metsälä J, Lundqvist A, Virta LJ, et al. (2013) Mother's and offspring's use of antibiotics and infant allergy to cow's milk. Epidemiology 24: 303-309. https://doi.org/10.1097/EDE.0b013e31827f520f
    [95] Loh W, Tang MLK (2018) The epidemiology of food allergy in the global context. Int J Environ Res Public Health 15: 2043. https://doi.org/10.3390/ijerph15092043
    [96] Simon D (2019) Recent advances in clinical allergy and immunology 2019. Int Arch Allergy Imm 180: 291-305. https://doi.org/10.1159/000504364
    [97] Oro AS, Guarino TJ, Driver R, et al. (1996) Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 97: 1402-1408. https://doi.org/10.1016/S0091-6749(96)70210-5
    [98] Cameron MH, Nilsagard Y (2018) Balance, gait, and falls in multiple sclerosis. Handb Clin Neurol 159: 237-250. https://doi.org/10.1016/B978-0-444-63916-5.00015-X
    [99] Rosiak K, Zagożdżon P (2017) Quality of life and social support in patients with multiple sclerosis. Psychiatr Pol 51: 923-935. https://doi.org/10.12740/PP/64709
    [100] Beiske AG, Naess H, Aarseth JH, et al. (2007) Health-related quality of life in secondary progressive multiple sclerosis. Mult Scler 13: 386-392. https://doi.org/10.1177/13524585070130030101
    [101] Lock C, Hermans G, Pedotti R, et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8: 500-508. https://doi.org/10.1038/nm0502-500
    [102] Pedotti R, DeVoss JJ, Youssef S, et al. (2003) Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. P Natl Acad Sci USA 100: 1867-1872. https://doi.org/10.1073/pnas.252777399
    [103] Musio S, Gallo B, Scabeni S, et al. (2006) A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J Immunol 176: 17-26. https://doi.org/10.4049/jimmunol.176.1.17
    [104] Lapilla M, Gallo B, Martinello M, et al. (2011) Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain microcirculation. J Leukocyte Biol 89: 259-267. https://doi.org/10.1189/jlb.0910486
    [105] Gregory GD, Robbie-Ryan M, Secor VH, et al. (2005) Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur J Immunol 35: 3478-3486. https://doi.org/10.1002/eji.200535271
    [106] Alonso A, Hernán MA, Ascherio A (2008) Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis. Acta Neurol Scand 117: 15-20.
    [107] Alonso A, Jick SS, Hernán MA (2006) Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 66: 572-575. https://doi.org/10.1212/01.wnl.0000198507.13597.45
    [108] Karimi P, Modarresi SZ, Sahraian MA, et al. (2013) The relation of multiple sclerosis with allergy and atopy: a case control study. Iran J Allergy Asthma Immunol 12: 182-189.
    [109] Krishna MT, Subramanian A, Adderley NJ, et al. (2019) Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis. Eur Respir J 54: 1900476. https://doi.org/10.1183/13993003.00476-2019
    [110] Mansouri B, Asadollahi S, Heidari K, et al. (2014) Risk factors for increased multiple sclerosis susceptibility in the Iranian population. J Clin Neurosci 21: 2207-2211. https://doi.org/10.1016/j.jocn.2014.04.020
    [111] Chen J, Taylor B, Winzenberg T, et al. (2020) Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis. Mult Scler 26: 1550-1559. https://doi.org/10.1177/1352458519872644
    [112] Lo LMP, Taylor BV, Winzenberg T, et al. (2021) Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal Study. Eur J Neurol 28: 2269-2279. https://doi.org/10.1111/ene.14887
    [113] Hill E, Abboud H, Briggs FBS (2019) Prevalence of asthma in multiple sclerosis: A United States population-based study. Mult Scler Relat Disord 28: 69-74. https://doi.org/10.1016/j.msard.2018.12.012
    [114] Sorensen A, Conway DS, Briggs FBS (2021) Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthma. Mult Scler Relat Disord 53: 103040. https://doi.org/10.1016/j.msard.2021.103040
    [115] Tremlett HL, Evans J, Wiles CM, et al. (2002) Asthma and multiple sclerosis: an inverse association in a case-control general practice population. QJM 95: 753-756. https://doi.org/10.1093/qjmed/95.11.753
    [116] Bergamaschi R, Villani S, Crabbio M, et al. (2009) Inverse relationship between multiple sclerosis and allergic respiratory diseases. Neurol Sci 30: 115-118. https://doi.org/10.1007/s10072-009-0036-8
    [117] Sahraian MA, Jafarian S, Sheikhbahaei S, et al. (2013) Respiratory tract rather than cutaneous atopic allergy inversely associate with multiple sclerosis: a case-control study. Clin Neurol Neurosur 115: 2099-2102. https://doi.org/10.1016/j.clineuro.2013.07.028
    [118] Pedotti R, Farinotti M, Falcone C, et al. (2009) Allergy and multiple sclerosis: a population-based case-control study. Mult Scler 15: 899-906. https://doi.org/10.1177/1352458509106211
    [119] Ren J, Ni H, Kim M, et al. (2017) Allergies, antibiotics use, and multiple sclerosis. Curr Med Res Opin 33: 1451-1456. https://doi.org/10.1080/03007995.2017.1325575
    [120] Skaaby T, Husemoen LL, Thuesen BH, et al. (2015) Specific IgE positivity against inhalant allergens and development of autoimmune disease. Autoimmunity 48: 282-288. https://doi.org/10.3109/08916934.2014.1003640
    [121] Manouchehrinia A, Edwards LJ, Roshanisefat H, et al. (2015) Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study. BMJ Open 5: e007806. https://doi.org/10.1136/bmjopen-2015-007806
    [122] Ponsonby AL, Dwyer T, van der Mei I, et al. (2006) Asthma onset prior to multiple sclerosis and the contribution of sibling exposure in early life. Clin Exp Immunol 146: 463-470. https://doi.org/10.1111/j.1365-2249.2006.03235.x
    [123] Hughes AM, Lucas RM, McMichael AJ, et al. (2013) Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially. Clin Exp Immunol 172: 466-474. https://doi.org/10.1111/cei.12077
    [124] Lopez CM, Yarrarapu SNS, Mendez MD (2022) Food allergies In: StatPearls, Treasure Island (FL): StatPearls Publishing.
    [125] Yu JW, Pekeles G, Legault L, et al. (2006) Milk allergy and vitamin D deficiency rickets: a common disorder associated with an uncommon disease. Ann Allerg Asthma Im 96: 615-619. https://doi.org/10.1016/S1081-1206(10)63558-2
    [126] Correale J, Ysrraelit MC, Gaitán MI (2009) Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 132: 1146-1160. https://doi.org/10.1093/brain/awp033
    [127] Ramagopalan SV, Dyment DA, Guimond C, et al. (2010) Childhood cow's milk allergy and the risk of multiple sclerosis: a population based study. J Neurol Sci 291: 86-88. https://doi.org/10.1016/j.jns.2009.10.021
    [128] Pichler J, Gerstmayr M, Szepfalusi Z, et al. (2002) 1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 52: 12-18. https://doi.org/10.1203/00006450-200207000-00005
    [129] Sakaguchi S, Yamaguchi T, Nomura T, et al. (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787. https://doi.org/10.1016/j.cell.2008.05.009
    [130] Mirzakhani H, Al-Garawi A, Weiss ST, et al. (2015) Vitamin D and the development of allergic disease: how important is it?. Clin Exp Allergy 45: 114-125. https://doi.org/10.1111/cea.12430
    [131] Danikowski KM, Jayaraman S, Prabhakar BS (2017) Regulatory T cells in multiple sclerosis and myasthenia gravis. J Neuroinflammation 14: 117. https://doi.org/10.1186/s12974-017-0892-8
    [132] Ashtari F, Jamshidi F, Shoormasti RS, et al. (2013) Cow's milk allergy in multiple sclerosis patients. J Res Med Sci 18: S62-S65.
    [133] Ashtari F, Jamshidi F, Shoormasti RS, et al. (2013) Fish and egg specific immunoglobin e in multiple sclerosis patients. Int J Prev Med 4: S185-S188.
    [134] Bourne T, Waltz M, Casper TC, et al. (2017) Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population. J Neurol Sci 375: 371-375. https://doi.org/10.1016/j.jns.2017.02.041
    [135] Fakih R, Diaz-Cruz C, Chua AS, et al. (2019) Food allergies are associated with increased disease activity in multiple sclerosis. J Neurol Neurosur Ps 90: 629-635. https://doi.org/10.1136/jnnp-2018-319301
    [136] Albatineh AN, Alroughani R, Al-Temaimi R (2020) Predictors of multiple sclerosis severity score in patients with multiple sclerosis. Int J MS Care 22: 233-238. https://doi.org/10.7224/1537-2073.2019-054
    [137] Parodi B, de Rosbo NK (2021) The gut-brain axis in multiple sclerosis. Is its dysfunction a pathological trigger or a consequence of the disease?. Front Immunol 12: 718220. https://doi.org/10.3389/fimmu.2021.718220
    [138] Agirman G, Yu KB, Hsiao EY (2021) Signaling inflammation across the gut-brain axis. Science 374: 1087-1092. https://doi.org/10.1126/science.abi6087
  • This article has been cited by:

    1. Ariyanatchi M., Vijayalakshmi G.M., Nonlinear Robust Adaptive Sliding Mode Control Strategies Involve a Fractional Ordered Approach to Reducing Dengue Vectors, 2024, 14, 26667207, 100406, 10.1016/j.rico.2024.100406
  • Reader Comments
  • © 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(4031) PDF downloads(141) Cited by(1)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog